Abstract Background Identifying Plasmodium vivax antigen-specific antibodies associated
with P. vivax infection and protective immunity is key to the development of serosurveillance …

Background Plasmodium vivax (P. vivax) is the dominant Plasmodium spp. causing the
disease malaria in low-transmission regions outside of Africa. These regions often feature …

Background Antibody responses as serological markers of Plasmodium vivax infection have
been shown to correlate with exposure, but little is known about the other factors that affect …

Serological markers are a promising tool for surveillance and targeted interventions for
Plasmodium vivax malaria. P. vivax is closely related to the zoonotic parasite P. knowlesi …

Plasmodium vivax remains a global health problem and its ability to cause relapses and
subpatent infections challenge control and elimination strategies. Even in low malaria …

Plasmodium vivax is now the dominant Plasmodium species causing malaria in Thailand,
yet little is known about naturally acquired immune responses to this parasite in this low …

Background Thailand is aiming to eliminate malaria by the year 2024. Plasmodium vivax
has now become the dominant species causing malaria within the country, and a high …

The utilisation of serological surveillance methods for malaria has the potential to identify
individuals exposed to Plasmodium vivax, including asymptomatic carriers. However, the …

Plasmodium vivax remains an important cause of malaria in South America and the Asia-
Pacific. Naturally acquired antibody responses against multiple P. vivax proteins have been …

Background Plasmodium vivax has the potential to infect 2.85 billion individuals worldwide.
Nevertheless, the limited number of studies investigating the immune status of individuals …